The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

In this episode of The Amazing Runner’s World Show, Aly admits to running “on vibes” and not paying much attention to heart ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a new study. The findings highlight how these important cancer screening tools can also ...

"Unlike any objects we know, these filaments really surprised us. Since then, we have been pondering what they are." ...

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...

A study led by bioengineers at the University of California San Diego sheds new light on how a type of heart valve disease, called aortic valve stenosis, progresses differently in males and females.

In the turbulent heart of the Milky Way, near the supermassive black hole Sagittarius A*, astronomers have uncovered a ...

Elevate Health Technologies announced that its Pulse AI software for medical practices is being used by Heart South ...

The brutality unleashed by Ugandan security forces on journalists during last week’s Kawempe North by-election was staggering ...

New hope offered by a pharmacy team for treating heart disease by sharing insights into the fundamental process of how the heart is formed in utero.